SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Role of molecular tests for cytologically indeterminate thyroid nodules.

{"article_title":"SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Role of molecular tests for cytologically indeterminate thyroid nodules.","author":"Lasolle H, Lopez J, Pattou F, Borson-Chazot F, Bardet S, Groussin L, Buffet C","journal_title":"Annales d'endocrinologie","issn":"2213-3941","isbn":"","publication_date":"2022-12-01","volume":"83","issue":"6","first_page":"395","page_count":"","accession_number":"36283464","doi":"10.1016\/j.ando.2022.10.006","publisher":"Elsevier","doctype":"Practice Guideline","subjects":"Thyroid Nodule diagnosis; Thyroid Nodule genetics; Thyroid Nodule therapy; Nuclear Medicine; Endocrinology; Thyroid Neoplasms pathology; Humans; Biopsy, Fine-Needle; Radionuclide Imaging; Retrospective Studies","interest_area":["Endocrinology"],"abstract":"The SFE-AFCE-SFMN 2022 consensus deals with the management of thyroid nodules, a condition that is a frequent reason for consultation in endocrinology. In more than 90% of cases, patients are euthyroid, with benign non-progressive nodules that do not warrant specific treatment. The clinician's objective is to detect malignant thyroid nodules at risk of recurrence and death, toxic nodules responsible for hyperthyroidism or compressive nodules warranting treatment. The diagnosis and treatment of thyroid nodules requires close collaboration between endocrinologists, nuclear medicine physicians and surgeons, but also involves other specialists. Therefore, this consensus statement was established jointly by 3 societies: the French Society of Endocrinology (SFE), French Association of Endocrine Surgery (AFCE) and French Society of Nuclear Medicine (SFMN); the various working groups included experts from other specialties (pathologists, radiologists, pediatricians, biologists, etc.). Because of the emerging role of molecular fine-needle cytology diagnostics, the French Endocrine Society convened a panel of experts to review the evidence for the diagnostic value of molecular tests performed on cytologically indeterminate thyroid nodules. Copyright \u00a9 2022. Published by Elsevier Masson SAS.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=36283464","isPdfLink":false,"isSAML":false,"an":"36283464","number_other":"","type_pub":"","issn_electronic":"2213-3941","languages":"English","language":"eng","date_entry":"Date Created: 20221025 Date Completed: 20221216 Latest Revision: 20231129","date_update":"20240105","titleSource":"Annales d'endocrinologie [Ann Endocrinol (Paris)] 2022 Dec; Vol. 83 (6), pp. 395-400. Date of Electronic Publication: 2022 Oct 23.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2022-12-01","description":"The SFE-AFCE-SFMN 2022 consensus deals with the management of thyroid nodules, a condition that is a frequent reason for consultation in endocrinology. In more than 90% of cases, patients are euthyroid, with benign non-progressive nodules that do not warrant specific treatment. The clinician's objective is to detect malignant thyroid nodules at risk of recurrence and death, toxic nodules responsible for hyperthyroidism or compressive nodules warranting treatment. The diagnosis and treatment of thyroid nodules requires close collaboration between endocrinologists, nuclear medicine physicians and surgeons, but also involves other specialists. Therefore, this consensus statement was established jointly by 3 societies: the French Society of Endocrinology (SFE), French Association of Endocrine Surgery (AFCE) and French Society of Nuclear Medicine (SFMN); the various working groups included experts from other specialties (pathologists, radiologists, pediatricians, biologists, etc.). Because of the emerging role of molecular fine-needle cytology diagnostics, the French Endocrine Society convened a panel of experts to review the evidence for the diagnostic value of molecular tests performed on cytologically indeterminate thyroid nodules.<br \/> (Copyright © 2022. Published by Elsevier Masson SAS.)","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&scope=site&db=mdl&AN=36283464&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Lasolle H, Lopez J, Pattou F, Borson-Chazot F, Bardet S, Groussin L, Buffet C"}